Vincent Milano - Net Worth and Insider Trading

Vincent Milano Net Worth

The estimated net worth of Vincent Milano is at least $76,215 dollars as of 2024-04-28. Vincent Milano is the Director of BioCryst Pharmaceuticals Inc and owns about 17,500 shares of BioCryst Pharmaceuticals Inc (BCRX) stock worth over $72,800. Vincent Milano is also the Director of Aceragen Inc and owns about 8,987 shares of Aceragen Inc (ACGN) stock worth over $3,415. Details can be seen in Vincent Milano's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Vincent Milano has not made any transactions after 2023-08-10 and currently still holds the listed stock(s).

Transaction Summary of Vincent Milano

To

Vincent Milano Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Vincent Milano owns 5 companies in total, including Aceragen Inc (ACGN) , Aclaris Therapeutics Inc (ACRS) , and Spark Therapeutics Inc (ONCE) among others .

Click here to see the complete history of Vincent Milano’s form 4 insider trades.

Insider Ownership Summary of Vincent Milano

Ticker Comapny Transaction Date Type of Owner
ACGN Aceragen Inc 2023-08-10 director & President & CEO
ACRS Aclaris Therapeutics Inc 2020-01-07 director
ONCE Spark Therapeutics Inc 2019-12-17 director
VNDA Vanda Pharmaceuticals Inc 2018-06-13 director
BCRX BioCryst Pharmaceuticals Inc 2021-11-24 director

Vincent Milano Latest Holdings Summary

Vincent Milano currently owns a total of 2 stocks. Among these stocks, Vincent Milano owns 17,500 shares of BioCryst Pharmaceuticals Inc (BCRX) as of November 24, 2021, with a value of $72,800 and a weighting of 95.52%. Vincent Milano also owns 8,987 shares of Aceragen Inc (ACGN) as of August 10, 2023, with a value of $3,415 and a weighting of 4.48%.

Latest Holdings of Vincent Milano

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
BCRX BioCryst Pharmaceuticals Inc 2021-11-24 17,500 4.16 72,800
ACGN Aceragen Inc 2023-08-10 8,987 0.38 3,415

Holding Weightings of Vincent Milano


Vincent Milano Form 4 Trading Tracker

According to the SEC Form 4 filings, Vincent Milano has made a total of 1 transactions in BioCryst Pharmaceuticals Inc (BCRX) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in BioCryst Pharmaceuticals Inc is the acquisition of 7,500 shares on November 24, 2021, which cost Vincent Milano around $91,425.

According to the SEC Form 4 filings, Vincent Milano has made a total of 6 transactions in Aceragen Inc (ACGN) over the past 5 years, including 0 buys and 6 sells. The most-recent trade in Aceragen Inc is the sale of 3,283 shares on August 10, 2023, which brought Vincent Milano around $1,740.

Insider Trading History of Vincent Milano

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Vincent Milano Trading Performance

GuruFocus tracks the stock performance after each of Vincent Milano's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Vincent Milano is 16.21%. GuruFocus also compares Vincent Milano's trading performance to market benchmark return within the same time period. The performance of stocks bought by Vincent Milano within 3 months outperforms 2 times out of 4 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Vincent Milano's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Vincent Milano

Average Return

-22.74%

Average return per transaction

Outperforming Transactions

0%

0 out of 4 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 18.72 16.21 -21.72 -22.74 -12.48 -41.75
Relative Return to S&P 500(%) 14.57 13.33 -24.29 -33.23 -24.72 -59.7

Vincent Milano Ownership Network

Ownership Network List of Vincent Milano

No Data

Ownership Network Relation of Vincent Milano


Vincent Milano Owned Company Details

What does Aceragen Inc do?

Who are the key executives at Aceragen Inc?

Vincent Milano is the director & President & CEO of Aceragen Inc. Other key executives at Aceragen Inc include director & 10 percent owner Pillar Invest Corp , 10 percent owner Atul Chopra , and director & other: See Remarks Novaquest Co-investment Fund Xv, L.p. .

Aceragen Inc (ACGN) Insider Trades Summary

Over the past 18 months, Vincent Milano made 1 insider transaction in Aceragen Inc (ACGN) with a net sale of 3,283. Other recent insider transactions involving Aceragen Inc (ACGN) include a net sale of 264,324 shares made by Atul Chopra , a net purchase of 21,147 shares made by Pillar Invest Corp , and a net sale of 51 shares made by Maxine Gowen .

In summary, during the past 3 months, insiders sold 0 shares of Aceragen Inc (ACGN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 273,476 shares of Aceragen Inc (ACGN) were sold and 26,965 shares were bought by its insiders, resulting in a net sale of 246,511 shares.

Aceragen Inc (ACGN)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Aceragen Inc Insider Transactions

No Available Data

Vincent Milano Mailing Address

Above is the net worth, insider trading, and ownership report for Vincent Milano. You might contact Vincent Milano via mailing address: C/o Viropharma Inc, 405 Eagleview Blvd, Exton Pa 19341.

Discussions on Vincent Milano

No discussions yet.